A complete application consists of:
All documents must be in English or include an official English translation.
If you have questions, send an email to FDArpp@orau.org Please include the reference code for this opportunity in your email.
A research project opportunity is currently available at the U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Office of Regulatory Affairs (ORA), Arkansas Regional Laboratory. The postdoctoral fellow will collaborate with multi-disciplinary research efforts within the NCTR/ORA Nanotechnology Core Facility. Collaborative and research activities may include:
The fellowship is within the Nanotechnology Core Facility where the following analytical techniques will be used to support these research activities: inductively coupled plasma-mass spectrometry (ICP-MS), asymmetric field flow fractionation (AFFF), centrifugal field flow fractionation(CFFF), x-ray diffraction (XRD), particle size analysis (multiple methods including dynamic light scattering, photon cross correlation spectroscopy, and particle tracking analysis), spectroscopy (FTIR, UV/VIS, fluorescence, XRF, Raman), atomic force microscopy (AFM), high resolution mass spectrometry (HRMS), and electron microscopy with elemental analysis capabilities.
The Nanotechnology Core Facility was developed to support the technical needs of scientists involved in determining the toxicity, safety, and characterization of nanomaterials. This facility supports research efforts at the FDA’s ORA, the National Center for Toxicological Research (NCTR), and the National Institute of Environmental Health Sciences National Toxicology Program.
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and CDC. The initial appointment is for one year, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at ORA in the Jefferson, AR, area. Participants do not become employees of ORA, NCTR, FDA or the program administrator, and there are no fringe benefits paid.
The target starting date is March 7, 2016. The FDA Jefferson Laboratory Complex is located approximately 25 miles South of Little Rock, Arkansas. The Campus houses NCTR (the primary research facility of the U.S. Food & Drug Administration) and the Arkansas Regional Laboratories of ORA.
The participant must have received a Ph.D. in chemistry or materials science with a strong emphasis in nanotechnology within the last five years. The applicant should have experience in the characterization of nanomaterials using spectroscopy, microscopy, or other current published methodologies.